Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Sanguine Biosciences
Information provided by (Responsible Party):
Sanguine Biosciences Identifier:
First received: August 23, 2013
Last updated: March 16, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2040
  Estimated Primary Completion Date: August 2020 (Final data collection date for primary outcome measure)